Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0548 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.9504 | 0.976 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.6022 | 0.6184 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0221 | 0.9738 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1064 | 0.1092 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1064 | 0.1092 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1981 | 0.2034 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1064 | 0.1191 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0548 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.6022 | 0.6184 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8931 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.6022 | 0.6184 |
Echinococcus multilocularis | geminin | 0.0205 | 0.8931 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1981 | 0.2034 |
Brugia malayi | nuclear hormone receptor | 0.0221 | 0.9738 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0548 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0548 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.8931 | 1 |
Brugia malayi | hypothetical protein | 0.002 | 0.0029 | 0.003 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0548 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1981 | 0.2034 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0548 | 0.5 |
Brugia malayi | hypothetical protein | 0.003 | 0.0548 | 0.0563 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0548 | 0.0563 |
Echinococcus granulosus | geminin | 0.0205 | 0.8931 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0548 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1981 | 0.2034 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0548 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.1095 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.